Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy

Prostate

The purpose of this study is to determine if treatment with apalutamide plus androgen deprivation therapy (ADT) before and after radical prostatectomy (RP) with pelvic lymph node dissection (pLND) in participants with high-risk localized or locally advanced prostate cancer results in an improvement in pathological complete response (pCR) rate and metastasis-free survival (MFS) based on conventional imaging, as compared to placebo plus ADT.
Prostate
III
Moses, Kelvin
NCT03767244
VICCURO19125

Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing

Prostate

This registry will evaluate treatment selection for patients with newly diagnosed, localized prostate cancer following Prolaris testing. It will measure the proportion of men who initially select treatment with active surveillance, the time frame between active surveillance selection and any change in treatment, and clinical outcomes.
Prostate
N/A
Moses, Kelvin
NCT04404894
VICCURO2089

Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer Trial

Kidney (Renal Cell)

Kidney (Renal Cell)
N/A
Moses, Kelvin
NCT04922307
VICCURO2114

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: